Role of BRAF and RAS Mutations in Extrathyroidal Extension in Papillary Thyroid Cancer
- 1 March 2016
- journal article
- research article
- Vol. 13 (2) , 171-181
Abstract
Background/Aim: Extrathyroidal extension (ETE) indicates the invasiveness of primary thyroid tumor into the adjacent tissue, and its importance as a prognostic factor overrides tumor size in classifying the cancer stage. The aim of this study was to determine the molecular basis of ETE in papillary thyroid carcinomas (PTCs). Materials and Methods: We systematically defined genes and pathways regulated in ETE using mutation and gene expression profiles from The Cancer Genome Atlas, and examined the effect of BRAF and RAS mutations on ETE. The significance of these genes was further validated using public microarray data. Results: Genes related to extracellular matrix and immune response were significantly up-regulated in ETE and ion-transport genes were often down-regulated. Differentiation properties and WNT signaling were also found to be altered by ETE. BRAF and RAS mutations were shown to have distinct effects on genes associated with ETE. Specifically, PAX8 and its downstream target WNT4 were differentially expressed according to mutation status in addition to ETE, indicating their critical roles in cell motility. Conclusion: BRAF V600E mutation predisposes PTC cells toward invasive phenotypes, while RAS mutation confers resistance to ETE. The differential regulation appears to be mediated through WNT4.Keywords
This publication has 27 references indexed in Scilit:
- Korea's Thyroid-Cancer “Epidemic” — Screening and OverdiagnosisNew England Journal of Medicine, 2014
- Thyroid transcription factors in development, differentiation and diseaseNature Reviews Endocrinology, 2014
- WNT signalling pathways as therapeutic targets in cancerNature Reviews Cancer, 2012
- Wnt4 inhibits cell motility induced by oncogenic RasOncogene, 2012
- WNT signaling in ovarian follicle biology and tumorigenesisTrends in Endocrinology & Metabolism, 2010
- Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populationsNature Genetics, 2009
- Extrathyroidal extension is not all equal: Implications of macroscopic versus microscopic extent in papillary thyroid carcinomaSurgery, 2008
- Tall Cell Variant of Papillary Thyroid Carcinoma without Extrathyroid Extension: Biologic Behavior and Clinical ImplicationsThyroid®, 2007
- Minimal Extrathyroid Extension Does Not Affect the Relapse-Free Survival of Patients with Papillary Thyroid Carcinoma Measuring 4 cm or Less over the Age of 45 YearsSurgery Today, 2005
- Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysisOncogene, 2005